Fitzgerald Joseph Michael
SEC CIK 1484186 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BSX | Boston Scientific | EVP, Pres, Interven Cardio | 64.2K | $4,514 | $62.16M | 82 | 2021-05-06 | 2026-07-31 |
Most active insiders at BSX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Mahoney Michael F | COB, Pres, CEO, Dir | $9.00M | $15.04M |
| 2 | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | — | $9.90M |
| 3 | Zane Ellen M | Dir | — | $2.57M |
| 4 | Butcher Arthur C | EVP, Grp Pres, MedSurg, APAC | — | $1.76M |
| 5 | LUDWIG EDWARD J | Dir | $430.3K | — |
| 6 | Habiger David C | Dir | $407.9K | — |
| 7 | Morano Susan E | Dir | $100.4K | — |
| 8 | Pegus Cheryl | Dir | $100.0K | — |
| 9 | O'Connor Padraig Andrew | EVP, Gbl Ops | — | — |
| 10 | O'Sullivan Miriam | SVP, Chief HR Off | — | — |
Transactions 82
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-08-03 16:29 | 2026-07-31 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | I - Discretionary | $46.73 | +64.2K | 64.2K | New | +$3.00M |
| DM | 2026-02-18 | 2026-02-13+ | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | F - Tax | $74.73 | -36.9K | 211.8K | -15% | -$2.76M |
| DM | 2026-02-18 | 2026-02-13+ | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | M - OptEx | $0.00 | +11.1K | 242.5K | +5% | $0 |
| DM | 2026-02-18 | 2026-02-13 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | A - Grant | $0.00 | +69.8K | 204.8K | +52% | $0 |
| D | 2026-02-17 | 2026-02-12 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | F - Tax | $74.12 | -1,612 | 169.9K | -0.9% | -$119.5K |
| D | 2026-02-17 | 2026-02-12 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | M - OptEx | $0.00 | +3,462 | 171.5K | +2% | $0 |
| M | 2025-11-14 | 2025-11-12+ | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | G - Gift | $0.00 | -10.3K | 177.7K | -5% | $0 |
| DM | 2025-11-04 | 2025-11-03 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | S - Sale+OE | $99.47 | -50.0K | 224.7K | -18% | -$4.97M |
| D | 2025-11-04 | 2025-11-03 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | M - OptEx | $26.15 | +50.0K | 228.3K | +28% | +$1.31M |
| D | 2025-10-01 | 2025-10-01 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | M - OptEx | $26.15 | +50.0K | 228.3K | +28% | +$1.31M |
| DM | 2025-10-01 | 2025-10-01 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | S - Sale+OE | $98.47 | -50.0K | 178.3K | -22% | -$4.92M |
| DM | 2025-09-03 | 2025-09-02 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | S - Sale+OE | $105.43 | -50.0K | 178.3K | -22% | -$5.27M |
| D | 2025-09-03 | 2025-09-02 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | M - OptEx | $26.15 | +50.0K | 228.3K | +28% | +$1.31M |
| D | 2025-08-04 | 2025-08-01 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | S - Sale+OE | $104.63 | -50.0K | 178.3K | -22% | -$5.23M |
| D | 2025-08-04 | 2025-08-01 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | M - OptEx | $26.15 | +50.0K | 228.3K | +28% | +$1.31M |
| D | 2025-07-02 | 2025-07-01 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | S - Sale+OE | $106.97 | -50.0K | 178.3K | -22% | -$5.35M |
| D | 2025-07-02 | 2025-07-01 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | M - OptEx | $26.15 | +50.0K | 228.3K | +28% | +$1.31M |
| D | 2025-06-04 | 2025-06-04 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | M - OptEx | $26.15 | +56.4K | 234.7K | +32% | +$1.47M |
| D | 2025-06-04 | 2025-06-04 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | S - Sale+OE | $102.88 | -56.4K | 178.3K | -24% | -$5.80M |
| M | 2025-02-26 | 2025-02-24+ | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | G - Gift | $0.00 | -2,040 | 178.3K | -1% | $0 |
| I | 2025-02-26 | 2025-02-24 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | G - Gift | $0.00 | +340 | 5,234 | +7% | $0 |
| 2025-02-21 | 2025-02-20 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | G - Gift | $0.00 | -1,000 | 180.4K | -0.6% | $0 | |
| DM | 2025-02-18 | 2025-02-14+ | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | M - OptEx | $0.00 | +12.5K | 179.1K | +7% | $0 |
| DM | 2025-02-18 | 2025-02-14+ | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | F - Tax | $106.11 | -5,853 | 181.4K | -3% | -$621.1K |
| D | 2025-02-14 | 2025-02-12 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | F - Tax | $105.77 | -1,579 | 174.7K | -0.9% | -$167.0K |
| D | 2025-02-14 | 2025-02-12 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | M - OptEx | $0.00 | +3,462 | 176.3K | +2% | $0 |
| 2025-02-13 | 2025-02-11 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | F - Tax | $105.98 | -14.4K | 172.9K | -8% | -$1.53M | |
| 2025-02-13 | 2025-02-11 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | A - Grant | $0.00 | +31.7K | 187.3K | +20% | $0 | |
| 2025-02-13 | 2024-12-10 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | S - Sale | $89.97 | -20 | 148.1K | -0.0% | -$1,799 | |
| 2025-02-13 | 2024-12-03 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | P - Purchase | $90.29 | +50 | 148.2K | +0.0% | +$4,514 | |
| D | 2025-01-03 | 2025-01-01 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | F - Tax | $89.32 | -6,425 | 155.6K | -4% | -$573.9K |
| D | 2025-01-03 | 2025-01-01 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | M - OptEx | $0.00 | +13.9K | 162.0K | +9% | $0 |
| M | 2024-11-26 | 2024-11-25+ | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | G - Gift | $0.00 | -12.3K | 148.1K | -8% | $0 |
| DM | 2024-10-08 | 2024-10-07 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | M - OptEx | $21.07 | +116.6K | 293.0K | +66% | +$2.46M |
| D | 2024-10-08 | 2024-10-07 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | S - Sale+OE | $85.00 | -132.5K | 160.5K | -45% | -$11.26M |
| 2024-08-29 | 2024-08-28 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | S - Sale | $80.00 | -14.1K | 176.4K | -7% | -$1.13M | |
| 2024-05-14 | 2024-05-13 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | G - Gift | $0.00 | -2,380 | 190.5K | -1% | $0 | |
| I | 2024-02-22 | 2024-02-20 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | I - Discretionary | $66.22 | -68.0K | 0 | -100% | -$4.50M |
| DM | 2024-02-20 | 2024-02-16+ | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | F - Tax | $65.82 | -5,692 | 191.0K | -3% | -$374.6K |
| DM | 2024-02-20 | 2024-02-16+ | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | M - OptEx | $0.00 | +11.8K | 190.7K | +7% | $0 |
| D | 2024-02-16 | 2024-02-14 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | F - Tax | $65.95 | -1,990 | 186.7K | -1% | -$131.2K |
| D | 2024-02-16 | 2024-02-14 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | M - OptEx | $0.00 | +4,362 | 188.7K | +2% | $0 |
| D | 2024-02-14 | 2024-02-12 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | G - Gift | $0.00 | -6,000 | 184.4K | -3% | $0 |
| DI | 2024-02-14 | 2024-02-12 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | G - Gift | $0.00 | +550 | 4,894 | +13% | $0 |
| 2024-02-08 | 2024-02-06 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | F - Tax | $0.00 | -16.4K | 190.4K | -8% | $0 | |
| 2024-02-08 | 2024-02-06 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | A - Grant | $0.00 | +33.3K | 206.8K | +19% | $0 | |
| 2024-01-16 | 2024-01-12 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | S - Sale | $60.00 | -11.7K | 173.5K | -6% | -$699.6K | |
| DM | 2024-01-02 | 2023-12-29+ | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | M - OptEx | $11.87 | +80.0K | 256.2K | +45% | +$949.1K |
| D | 2024-01-02 | 2024-01-01 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | F - Tax | $57.81 | -10.9K | 185.1K | -6% | -$630.6K |
| D | 2024-01-02 | 2023-12-29 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | S - Sale+OE | $57.50 | -81.9K | 174.2K | -32% | -$4.71M |
| 2023-09-21 | 2023-09-20 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | S - Sale | $55.00 | -15.9K | 198.0K | -7% | -$872.7K | |
| D | 2023-05-17 | 2023-05-16 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | M - OptEx | $13.08 | +56.9K | 277.2K | +26% | +$744.5K |
| D | 2023-05-17 | 2023-05-16 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | S - Sale+OE | $53.60 | -63.3K | 213.9K | -23% | -$3.39M |
| D | 2023-02-22 | 2023-02-21 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | M - OptEx | $0.00 | +3,895 | 222.2K | +2% | $0 |
| D | 2023-02-22 | 2023-02-21 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | F - Tax | $46.23 | -1,923 | 220.3K | -0.9% | -$88.9K |
| A | 2023-02-21 | 2023-02-15 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | F - Tax | $47.29 | -2,278 | 212.2K | -1% | -$107.7K |
| DM | 2023-02-21 | 2023-02-16+ | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | M - OptEx | $0.00 | +11.8K | 216.1K | +6% | $0 |
| DM | 2023-02-21 | 2023-02-16+ | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | F - Tax | $46.52 | -5,691 | 218.3K | -3% | -$264.8K |
| D | 2023-02-16 | 2023-02-15 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | M - OptEx | $0.00 | +4,615 | 214.4K | +2% | $0 |
| D | 2023-02-16 | 2023-02-15 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | F - Tax | $47.29 | -2,488 | 212.0K | -1% | -$117.7K |
| DM | 2023-02-15 | 2023-02-09+ | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | G - Gift | $0.00 | -13.5K | 209.8K | -6% | $0 |
| DI | 2023-02-15 | 2023-02-09 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | G - Gift | $0.00 | +630 | 4,344 | +17% | $0 |
| D | 2023-01-03 | 2023-01-01 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | M - OptEx | $0.00 | +13.1K | 230.0K | +6% | $0 |
| D | 2023-01-03 | 2023-01-01 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | F - Tax | $46.27 | -6,658 | 223.3K | -3% | -$308.1K |
| D | 2022-12-14 | 2022-12-13 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | S - Sale+OE | $47.78 | -79.3K | 216.9K | -27% | -$3.79M |
| D | 2022-12-14 | 2022-07-29 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | G - Gift | $0.00 | -1,000 | 216.9K | -0.5% | $0 |
| D | 2022-12-14 | 2022-12-13 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | M - OptEx | $7.39 | +79.3K | 296.1K | +37% | +$585.8K |
| D | 2022-03-07 | 2022-03-03 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Pres, Cardiology | M - OptEx | $0.00 | +3,603 | 219.7K | +2% | $0 |
| D | 2022-03-07 | 2022-03-03 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Pres, Cardiology | F - Tax | $43.96 | -1,779 | 217.9K | -0.8% | -$78.2K |
| D | 2022-02-23 | 2022-02-21 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Pres, Cardiology | F - Tax | $42.55 | -1,923 | 216.0K | -0.9% | -$81.8K |
| D | 2022-02-23 | 2022-02-21 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Pres, Cardiology | M - OptEx | $0.00 | +3,895 | 218.0K | +2% | $0 |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Pres, Cardiology | M - OptEx | $0.00 | +7,872 | 214.3K | +4% | $0 |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Pres, Cardiology | F - Tax | $42.70 | -3,885 | 212.2K | -2% | -$165.9K |
| D | 2022-02-17 | 2022-02-07 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Pres, Cardiology | G - Gift | $0.00 | -2,780 | 207.8K | -1% | $0 |
| DI | 2022-02-17 | 2022-02-07 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Pres, Cardiology | G - Gift | $0.00 | +1,390 | 7,428 | +23% | $0 |
| D | 2022-02-17 | 2022-02-15 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Pres, Cardiology | F - Tax | $44.01 | -2,278 | 210.1K | -1% | -$100.3K |
| D | 2022-02-17 | 2022-02-15 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Pres, Cardiology | M - OptEx | $0.00 | +4,614 | 212.4K | +2% | $0 |
| D | 2022-01-03 | 2022-01-01 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Pres, Cardiology | M - OptEx | $0.00 | +14.0K | 217.6K | +7% | $0 |
| D | 2022-01-03 | 2022-01-01 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Pres, Cardiology | F - Tax | $42.48 | -7,099 | 210.5K | -3% | -$301.6K |
| D | 2021-07-27 | 2021-07-27 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Pres, Interven Cardio | S - Sale+OE | $45.00 | -105.5K | 203.6K | -34% | -$4.75M |
| D | 2021-07-27 | 2021-07-27 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Pres, Interven Cardio | M - OptEx | $6.28 | +70.3K | 309.1K | +29% | +$441.5K |
| D | 2021-07-27 | 2021-05-06 | BSX | Boston Scientific | Fitzgerald Joseph Michael | EVP, Pres, Interven Cardio | G - Gift | $0.00 | -12.0K | 238.8K | -5% | $0 |
Purchase Sale Sale after option exercise All abbreviations